Clinical Drug Experience Knowledgebase

capecitabine (xeloda) (1 trial)

docetaxel (taxotere) (2 trials)

eribulin (halaven) (2 trials)

gemcitabine (gemzar) (1 trial)

paclitaxel (taxol) (3 trials)

pertuzumab (perjeta) (2 trials)

trastuzumab (herceptin) (2 trials)

vinorelbine (navelbine) (1 trial)

anastrozole (arimidex) (1 trial)

bevacizumab (avastin) (1 trial)

buserelin (receptal) (1 trial)

exemestane (aromasin) (1 trial)

fulvestrant (faslodex) (1 trial)

goserelin (zoladex) (1 trial)

letrozole (femara) (1 trial)

leuprolide (lupron) (1 trial)